Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients

Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients

Fibroblast growth factor receptor (FGFR) genomic alterations (GAs) represent an actionable target, key to the pathogenesis of some urothelial cancers (UCs). Though FGFR GAs are common in noninvasive UC, little is known about their role in the metastatic(m) setting and response to therapy. This study...

Full description

Bibliographic Details
Main Authors: Elena Sevillano Fernández, Rodrigo Madurga de Lacalle, Juan Francisco Rodriguez Moreno, Arantzazu Barquín García, Mónica Yagüe Fernández, Paloma Navarro Alcaraz, María Barba Llacer, Miguel Quiralte Pulido, Jesús García-Donás Jiménez
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
FGFR
independent factor
metastatic urothelial cancer
Online Access:https://www.mdpi.com/2077-0383/11/15/4483

Internet

https://www.mdpi.com/2077-0383/11/15/4483

Similar Items